Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Shareholders Equity (Quarterly) : 55.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.20M |
| March 31, 2026 | 11.59M |
| December 31, 2025 | 16.92M |
| September 30, 2025 | 46.19M |
| June 30, 2025 | 48.01M |
| March 31, 2025 | 49.88M |
| December 31, 2024 | 54.39M |
| September 30, 2024 | 95.23M |
| June 30, 2024 | 101.02M |
| March 31, 2024 | 91.33M |
| December 31, 2023 | 98.30M |
| September 30, 2023 | 11.20M |
| June 30, 2023 | 12.79M |
| March 31, 2023 | 14.27M |
| December 31, 2022 | 18.62M |
| September 30, 2022 | 22.70M |
| June 30, 2022 | 28.62M |
| March 31, 2022 | 36.11M |
| December 31, 2021 | 43.90M |
| September 30, 2021 | 50.11M |
| June 30, 2021 | 56.13M |
| March 31, 2021 | 61.42M |
| December 31, 2020 | 12.16M |
| September 30, 2020 | 12.46M |
| June 30, 2020 | 16.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.769M |
| December 31, 2019 | 16.05M |
| September 30, 2019 | 22.82M |
| June 30, 2019 | 29.98M |
| March 31, 2019 | 12.85M |
| December 31, 2018 | 19.60M |
| September 30, 2018 | 26.03M |
| June 30, 2018 | 32.87M |
| March 31, 2018 | 40.98M |
| December 31, 2017 | 47.80M |
| September 30, 2017 | 54.01M |
| June 30, 2017 | 9.634M |
| March 31, 2017 | 14.28M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 3.362M |
| September 30, 2015 | 6.476M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 15.57M |
| September 30, 2014 | |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.97M |
| Total Liabilities (Quarterly) | 10.77M |
| Current Ratio | 4.270 |